OTCMKTS:HKMPF

Hikma Pharmaceuticals News Headlines

$33.00
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$33.00
Now: $33.00
$33.00
50-Day Range
$30.15
MA: $31.76
$37.00
52-Week Range
$26.20
Now: $33.00
$42.00
Volume100 shs
Average Volume749 shs
Market Capitalization$8.00 billion
P/E Ratio22.00
Dividend Yield0.48%
Beta0.41

Headlines

Hikma Pharmaceuticals (OTCMKTS HKMPF) News Headlines Today

SourceHeadline
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Receives Consensus Rating of "Buy" from AnalystsHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - April 13 at 4:58 AM
Hikma Pharmaceuticals (OTCMKTS:HKMPF) Upgraded by Morgan Stanley to OverweightHikma Pharmaceuticals (OTCMKTS:HKMPF) Upgraded by Morgan Stanley to Overweight
americanbankingnews.com - April 6 at 8:54 AM
Brokers Set Expectations for Hikma Pharmaceuticals PLCs FY2021 Earnings (OTCMKTS:HKMPF)Brokers Set Expectations for Hikma Pharmaceuticals PLC's FY2021 Earnings (OTCMKTS:HKMPF)
americanbankingnews.com - April 2 at 8:50 AM
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) to Post FY2025 Earnings of $2.50 Per Share, Jefferies Financial Group ForecastsHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) to Post FY2025 Earnings of $2.50 Per Share, Jefferies Financial Group Forecasts
americanbankingnews.com - April 1 at 9:00 AM
Hikma Pharmaceuticals (OTCMKTS:HKMPF) Rating Increased to Buy at Jefferies Financial GroupHikma Pharmaceuticals (OTCMKTS:HKMPF) Rating Increased to Buy at Jefferies Financial Group
americanbankingnews.com - March 31 at 9:30 AM
Hikma Pledges additional $40,000 to local US food banks and pantries in fight against hungerHikma Pledges additional $40,000 to local US food banks and pantries in fight against hunger
finance.yahoo.com - March 18 at 9:58 AM
Hikmas commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change ReportHikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
finance.yahoo.com - January 13 at 8:36 AM
Can MGE Energy, Inc. (NASDAQ:MGEE) Performance Keep Up Given Its Mixed Bag Of Fundamentals?Can MGE Energy, Inc. (NASDAQ:MGEE) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
finance.yahoo.com - November 16 at 7:49 AM
MGE Energy to Present at EEI Financial ConferenceMGE Energy to Present at EEI Financial Conference
finance.yahoo.com - November 9 at 5:55 PM
Hikma To Expand Partnership With Arecor; Adds Ready-to-administer Injectable Product Hikma To Expand Partnership With Arecor; Adds Ready-to-administer Injectable Product
markets.businessinsider.com - October 20 at 4:04 AM
Amarin Shares Sink As Generic Competition for Fish Oil Heart Drug Looks More CertainAmarin Shares Sink As Generic Competition for Fish Oil Heart Drug Looks More Certain
finance.yahoo.com - September 4 at 10:47 AM
MGE Energy Issues Second-Quarter Financial UpdateMGE Energy Issues Second-Quarter Financial Update
finance.yahoo.com - August 10 at 10:10 AM
Hikma Pharmaceuticals PLC -- Moody's announces completion of a periodic review of ratings of Hikma Pharmaceuticals PLCHikma Pharmaceuticals PLC -- Moody's announces completion of a periodic review of ratings of Hikma Pharmaceuticals PLC
finance.yahoo.com - August 7 at 1:19 PM
Hikma Pharmaceuticals beats on revenueHikma Pharmaceuticals beats on revenue
seekingalpha.com - August 7 at 8:14 AM
Hikma Pharma pretax profit climbs 21%Hikma Pharma pretax profit climbs 21%
msn.com - August 7 at 3:14 AM
If You Like EPS Growth Then Check Out Hikma Pharmaceuticals (LON:HIK) Before It's Too LateIf You Like EPS Growth Then Check Out Hikma Pharmaceuticals (LON:HIK) Before It's Too Late
finance.yahoo.com - July 17 at 7:36 AM
Hikma Pharmaceuticals Plc: A High-Quality Company Trading At A Reasonable PriceHikma Pharmaceuticals Plc: A High-Quality Company Trading At A Reasonable Price
seekingalpha.com - June 24 at 10:42 PM
MGE Energy Issues June 2020 Interim ReportMGE Energy Issues June 2020 'Interim Report'
finance.yahoo.com - June 15 at 12:24 PM
Hikma receives FDA approval for its generic Vascepa®Hikma receives FDA approval for its generic Vascepa®
markets.businessinsider.com - May 22 at 2:16 AM
Is Amarin Stock a Buy?Is Amarin Stock a Buy?
finance.yahoo.com - May 19 at 7:30 AM
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USPHikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
finance.yahoo.com - May 12 at 3:22 AM
Hikma Extends Recall Of Ketorolac Tromethamine Injection Hikma Extends Recall Of Ketorolac Tromethamine Injection
www.rttnews.com - March 9 at 1:20 PM
BRIEF-Hikma Pharma Extends Voluntary Nationwide Recall Of Ketorolac Tromethamine Injections Due To Potential Small Particulate PresenceBRIEF-Hikma Pharma Extends Voluntary Nationwide Recall Of Ketorolac Tromethamine Injections Due To Potential Small Particulate Presence
www.reuters.com - March 5 at 10:27 AM
Hikma Pharma extends recall of pain med ketorolac tromethamineHikma Pharma extends recall of pain med ketorolac tromethamine
seekingalpha.com - March 5 at 10:27 AM
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the USHikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
finance.yahoo.com - February 27 at 8:14 AM
Airlines slump in London as FTSE 100 slammed by coronavirus fearsAirlines slump in London as FTSE 100 slammed by coronavirus fears
finance.yahoo.com - February 27 at 8:14 AM
BRIEF-Hikma Pharmaceuticals FY Operating Profit Rose 33% To $493 MlnBRIEF-Hikma Pharmaceuticals FY Operating Profit Rose 33% To $493 Mln
feeds.reuters.com - February 27 at 4:31 AM
Hikma Pharmaceuticals Signs Distribution Deal In Egypt With ChiesiHikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi
www.lse.co.uk - January 13 at 6:38 AM
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technologyHikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
finance.yahoo.com - January 9 at 3:10 AM
Hikma Pharmaceuticals PLC's (LON:HIK) 1.4% Dividend Yield Looks Pretty InterestingHikma Pharmaceuticals PLC's (LON:HIK) 1.4% Dividend Yield Looks Pretty Interesting
finance.yahoo.com - January 2 at 11:44 AM
Amarins Patent Infringement Lawsuit, And Other News: The Good, Bad, And Ugly Of BiopharmaAmarin's Patent Infringement Lawsuit, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - January 2 at 3:45 AM
Estimating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)Estimating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
finance.yahoo.com - December 31 at 9:06 PM
Hikma Pharmaceuticals Reiterates Group FY Outlook - Quick Facts Hikma Pharmaceuticals Reiterates Group FY Outlook - Quick Facts
markets.businessinsider.com - November 7 at 3:58 AM
Can Hikma Pharmaceuticals PLC's (LON:HIK) ROE Continue To Surpass The Industry Average?Can Hikma Pharmaceuticals PLC's (LON:HIK) ROE Continue To Surpass The Industry Average?
finance.yahoo.com - September 16 at 10:08 AM
HKMPF or ZTS: Which Is the Better Value Stock Right Now?HKMPF or ZTS: Which Is the Better Value Stock Right Now?
finance.yahoo.com - August 14 at 10:20 AM
Edited Transcript of HIK.L earnings conference call or presentation 9-Aug-19 8:30am GMTEdited Transcript of HIK.L earnings conference call or presentation 9-Aug-19 8:30am GMT
finance.yahoo.com - August 9 at 4:59 PM
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the HomePillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
finance.yahoo.com - May 29 at 10:35 AM
Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USPHikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP
finance.yahoo.com - May 13 at 10:50 AM
Hikma Sponsors MIT Grand Hack to Support Global Healthcare InnovationHikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation
finance.yahoo.com - May 13 at 10:50 AM
Ironwood Commences Phase I Study on IW-6463 for CNS DisordersIronwood Commences Phase I Study on IW-6463 for CNS Disorders
finance.yahoo.com - January 24 at 4:32 PM
Ocular (OCUL) Submits an sNDA for Eye Pain Drug DextenzaOcular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza
finance.yahoo.com - January 11 at 4:25 PM
Karyopharm Files MAA for Myeloma Candidate Selinexor in EUKaryopharm Files MAA for Myeloma Candidate Selinexor in EU
finance.yahoo.com - January 9 at 10:37 AM
Flexion Starts Phase III Enrollment on Zilretta for Hip OAFlexion Starts Phase III Enrollment on Zilretta for Hip OA
finance.yahoo.com - January 3 at 4:06 PM
Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib StudySpectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study
finance.yahoo.com - January 3 at 4:06 PM
Spectrum Pharma Files BLA for Neutropenia Candidate RolontisSpectrum Pharma Files BLA for Neutropenia Candidate Rolontis
finance.yahoo.com - December 28 at 10:29 AM
Hikma Pharmaceuticals Plc (HKMPF)Hikma Pharmaceuticals Plc (HKMPF)
www.zacks.com - December 25 at 3:54 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.